VEGFA and neoplasm: In principle, TACE exacerbates tumor hypoxia and triggers a corresponding cellular response, potentially leading to the upregulation of both vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF), hence fostering tumor revascularization and advancement.10, 11